Objective: To evaluate the usefulness of two-site blood cultures for the documentation of bacterial clearance during initial treatment of culture proven neonatal sepsis.
Introduction
Eradication of bacteremia in response to antimicrobial therapy in septic very low birth weight infants is often delayed, even in the presence of apparent clinical improvement. To assess therapeutic efficacy, several authors have suggested that when initial blood cultures are positive then repeat cultures should be obtained shortly after initiation of antimicrobial therapy. 1, 2 In practice, the duration of antimicrobial therapy is traditionally calculated from the first day of the last negative blood culture. However, there is limited information to guide the practitioner on the optimal number of blood cultures that should be obtained to document the response to antimicrobial therapy.
We have previously shown that multiple site blood cultures are not necessary to diagnose neonatal sepsis. 3 However, once antimicrobial therapy is started, the blood bacterial density may be reduced rendering a single site blood culture insufficient to document either absence or presence of persistent bacteremia. 4 Proper documentation of clearance of bacteremia with blood culture is important because false-negative blood cultures could lead to a shorter course of antimicrobial treatment with potential adverse consequences.
We hypothesized that multiple site blood cultures obtained during antimicrobial therapy for proven sepsis would lead to better ascertainment of clearance of bacteremia.
Methods
Clinical data were prospectively collected on 216 consecutive infants who had diagnostic blood cultures taken from two different peripheral sites for the evaluation of possible early-or late-onset sepsis in the neonatal intensive care unit at the State University of New York at Stony Brook. Indications for the diagnostic blood cultures and the results of that study have been previously reported. 3 When diagnostic cultures were reported to be positive then central lines were removed, initial empiric antimicrobial therapy was altered according to the susceptibility of the isolate, and optimal antimicrobial drug concentrations were monitored. Details of the blood culture collection and skin cleansing methods have been summarized elsewhere. 3 At the discretion of the attending neonatologist, beginning 48 to 72 h after initiation of antimicrobial therapy, follow-up blood cultures were drawn from two different peripheral sites with a minimum of 1.0 ml of blood from each site. Repeat cultures were obtained every 24 to 48 h until both blood cultures became negative. Follow-up blood cultures were considered positive if they grew the same organism, with similar sensitivity patterns, as the original diagnostic cultures. None of the study infants had central lines at the time of the follow-up blood cultures.
This study was initiated as a quality assurance project; use of these data for research purposes was subsequently approved by the Committee on Research Involving Human Subjects of the State University of New York at Stony Brook.
Results Twenty (9.2%) of 216 neonates had 22 episodes of culture-proven sepsis at a median age of 18 days. Only one of the 20 neonates with a positive blood culture had an episode of early-onset sepsis (Listeria monocytogenes) whereas all other episodes of blood culture proven sepsis were late onset (>7 days of life). All neonates with positive diagnostic blood cultures had the same organism, with identical sensitivity patterns, obtained from the two different peripheral sites.
Follow-up two-site cultures were drawn on 25 occasions at a median interval of 3 days after start of antimicrobial therapy during 17 episodes of culture-proven sepsis in 15 infants. Follow-up cultures to document clearance of bacteremia were not drawn in five septic infants -one infant died before cultures could be repeated and in four infants repeat cultures were deemed unnecessary owing to interval clinical improvement.
On 12 occasions, follow-up blood cultures from both sites were negative. On eight occasions in four infants, follow-up blood cultures grew the same organisms from both sites (methicillinresistant Staphylococcus aureus (MRSA) in two infants on five occasions, Staphylococcus epidermidis in one infant on one occasion, MRSA Plus Candida albicans in one infant on one occasion and Candida albicans alone in the same infant on one occasion). Follow-up two-site blood cultures on five occasions in another four infants (27% of all patients with follow-up cultures) grew organisms from one site but not from the second site (Staphylococcus warnerii in one infant on two occasions, Staphylococcus epidermidis on one occasion, Klebsiella pneumoniae on one occasion and Listeria monocytogenes on one occasion).
Two infants with persistent bacteremia, owing to Staphylococcus epidermidis and MRSA respectively, were noted to have skin abscesses (intravenous catheter insertion site or incision site for patent ductus arteriosus ligation). The infant with early-onset Listeria monocytogenes bacteremia died, all other infants survived.
Discussion
Empirically chosen antimicrobial treatment regimens have been shown to be effective, and have contributed to the decrease of neonatal morbidity and mortality from neonatal sepsis, but little effort has been made to prospectively analyze the appropriate duration of antimicrobial treatment. 5 The practice of performing follow-up blood cultures to document clearance of bacteremia in response to antimicrobial therapy, and the calculation of an arbitrary 'complete course' of antimicrobial therapy from the day of the last negative blood culture seems to be logical, although these recommendations have never been critically evaluated. Nevertheless, our study suggests that if blood cultures are repeated to document the clearance of bacteremia in response to antimicrobial therapy then a single site blood culture may not be sufficient. The most likely explanation for a false-negative result in the presence of persistent bacteremia is a low density of bacteria in the blood. The inhibitory effect of antibiotics in the blood culture as well as over-dilution of the small volume of blood obtained during culture may also be explanations. Several previous studies 3, 4, 6 have investigated the usefulness of multiple site blood cultures in the initial evaluation for neonatal sepsis. The current study is the first to provide data regarding the usefulness of two-site blood cultures for documentation of the clearance of bacteremia after initiation of antimicrobial therapy. The purpose of our study was not to evaluate the risk factors responsible for persistent bacteremia and associated focal complications but solely to evaluate the role of two-site blood cultures to document the clearance of bacteremia during antimicrobial therapy.
This study should be considered a pilot study as the number of neonates with blood culture proven sepsis actually needed to provide a robust estimate of false-negative blood cultures during early treatment is beyond the scope of a single center. Nevertheless, our preliminary data indicate that false-negative cultures occur in a substantial percentage of treated infants. Therefore we conclude that multiple site follow-up blood cultures obtained during antimicrobial therapy in neonates for sepsis would lead to better ascertainment of the clearance of bacteremia than single cultures.
